Miller Howard Investments’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,666
Closed -$254K 201
2023
Q3
$254K Sell
4,666
-9
-0.2% -$533 0.01% 178
2023
Q2
$315K Hold
4,675
0.01% 172
2023
Q1
$241K Buy
4,675
+49
+1% +$2.38K 0.01% 186
2022
Q4
$213K Hold
4,626
0.01% 195
2022
Q3
$234K Buy
4,626
+11
+0.2% +$550 0.01% 182
2022
Q2
$210K Buy
+4,615
New +$206K 0.01% 189

Other funds holding LMAT

Miller Howard Investments's LMAT Position: Q4 2023 in Review

Miller Howard Investments sold out of LeMaitre Vascular (LMAT) in Q4 2023, closing a stake of 4,666 shares — an estimated $254K sold.

Miller Howard Investments first reported a position in LMAT in Q2 2022 and held it in 6 quarters. The position peaked at $315K in Q2 2023. 227 funds tracked by Wall St. Rank hold LMAT as of Q4 2023.

  • Miller Howard Investments reported no remaining LeMaitre Vascular position as of Q4 2023 after selling out during the quarter.
  • Miller Howard Investments sold 4,666 LeMaitre Vascular shares in Q4 2023, an estimated $254K.
  • Miller Howard Investments first reported a position in LeMaitre Vascular in Q2 2022 and held it in 6 quarters.
  • Miller Howard Investments's LeMaitre Vascular position peaked at $315K in Q2 2023.
  • 227 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2023.

Based on Miller Howard Investments's 13F filing for Q4 2023, filed 26 Jan 2024.